Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 7 studies | 31% ± 14% | |
Mueller cell | 6 studies | 30% ± 9% | |
astrocyte | 4 studies | 32% ± 12% |
Insufficient scRNA-seq data for expression of RAX at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 64% | 16.10 | 1160 / 1809 | 0% | 0.01 | 2 / 472 |
brain | 36% | 7.77 | 955 / 2642 | 2% | 0.06 | 13 / 705 |
prostate | 18% | 3.31 | 44 / 245 | 2% | 0.16 | 9 / 502 |
eye | 0% | 0 | 0 / 0 | 16% | 1.81 | 13 / 80 |
esophagus | 14% | 1.18 | 197 / 1445 | 0% | 0 | 0 / 183 |
thymus | 9% | 0.56 | 60 / 653 | 0% | 0 | 0 / 605 |
uterus | 1% | 0.06 | 2 / 170 | 6% | 0.40 | 29 / 459 |
ovary | 3% | 0.16 | 5 / 180 | 4% | 0.11 | 19 / 430 |
peripheral blood | 6% | 0.66 | 60 / 929 | 0% | 0 | 0 / 0 |
lung | 4% | 0.60 | 21 / 578 | 3% | 0.16 | 31 / 1155 |
kidney | 4% | 1.47 | 4 / 89 | 1% | 0.09 | 11 / 901 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.13 | 2 / 45 |
adipose | 4% | 0.25 | 52 / 1204 | 0% | 0 | 0 / 0 |
liver | 4% | 0.40 | 8 / 226 | 0% | 0.00 | 1 / 406 |
blood vessel | 4% | 0.19 | 47 / 1335 | 0% | 0 | 0 / 0 |
breast | 2% | 0.10 | 10 / 459 | 1% | 0.01 | 6 / 1118 |
adrenal gland | 2% | 0.11 | 4 / 258 | 1% | 0.02 | 2 / 230 |
stomach | 1% | 0.19 | 4 / 359 | 1% | 0.02 | 3 / 286 |
spleen | 2% | 0.09 | 5 / 241 | 0% | 0 | 0 / 0 |
intestine | 1% | 0.06 | 11 / 966 | 0% | 0.00 | 1 / 527 |
pancreas | 1% | 0.09 | 4 / 328 | 0% | 0 | 0 / 178 |
heart | 1% | 0.05 | 10 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.04 | 7 / 803 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.01 | 4 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060173 | Biological process | limb development |
GO_0007601 | Biological process | visual perception |
GO_0043010 | Biological process | camera-type eye development |
GO_0007389 | Biological process | pattern specification process |
GO_0021854 | Biological process | hypothalamus development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | RAX |
Protein name | Retinal homeobox protein Rx Retinal homeobox protein Rx (Retina and anterior neural fold homeobox protein) Retina and anterior neural fold homeobox |
Synonyms | RX |
Description | FUNCTION: Plays a critical role in eye formation by regulating the initial specification of retinal cells and/or their subsequent proliferation. Binds to the photoreceptor conserved element-I (PCE-1/Ret 1) in the photoreceptor cell-specific arrestin promoter. |
Accessions | G3V2C8 ENST00000334889.4 [Q9Y2V3-1] ENST00000555288.1 ENST00000256852.7 [Q9Y2V3-2] A0A127AXB3 A0A127AXF0 A0A127AYS6 A0A127AXH5 Q9Y2V3 |